Small molecule NLRP3 inhibitors like JC‐124 and MCC950 have been found to strongly promote pro‐inflammatory cytokines, chemokines, and ROS in AD; however, these along with more thorough analyses of the results may yield delightfully unexpected outcomes.16, 136, 137, 138. Here, NLRP3 is linked to Alzheimer disease.